dihexa fda approval status 2026 Undercutting HHS Secretary Robert F. Kennedy Jr.'s recent push to dihexa fda approval status 2026

Safety & Contraindications Regulatory reality first: Retatrutide is investigational and not approved by the FDA or EMA for any indication

Most large cagrilintide weight-loss figures actually come from CagriSema, so they describe cagrilintide plus a GLP-1 analog together not cagrilintide on its own

Men should aim to get 2.4 micrograms per day

The store, which this masthead has chosen not to name and which did not respond to requests for comment, is one of dozens of online sellers, operating in an unregulated, but potentially highly lucrative pharmaceutical Wild West

Are you leveraging AI to its full potential in your enterprise